CD4 and neoplasm: To evaluate the correlation between Tregs in the blood and the tumor advancement stage, the ratios of CD4+/CD25+/FoxP3+ lymphocytes were analyzed in the blood of patients with invasive tumors in relation to the phase of tumor development, as indicated by pT stage.